Morgan Stanley’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.3K | Buy |
507
+191
| +60% | +$11K | ﹤0.01% | 6520 |
|
|
2025
Q1 | $20.9K | Sell |
316
-10,302
| -97% | -$682K | ﹤0.01% | 6559 |
|
|
2024
Q4 | $670K | Buy |
10,618
+9,956
| +1,504% | +$628K | ﹤0.01% | 5296 |
|
|
2024
Q3 | $31K | Sell |
662
-382
| -37% | -$17.9K | ﹤0.01% | 6354 |
|
|
2024
Q2 | $47.7K | Sell |
1,044
-5,046
| -83% | -$231K | ﹤0.01% | 6191 |
|
|
2024
Q1 | $234K | Sell |
6,090
-38,752
| -86% | -$1.49M | ﹤0.01% | 5682 |
|
|
2023
Q4 | $2.05M | Buy |
44,842
+44,404
| +10,138% | +$2.03M | ﹤0.01% | 4910 |
|
|
2023
Q3 | $14K | Hold |
438
| – | – | ﹤0.01% | 6601 |
|
|
2023
Q2 | $6.26K | Sell |
438
-600
| -58% | -$8.57K | ﹤0.01% | 6933 |
|
|
2023
Q1 | $31K | Sell |
1,038
-962
| -48% | -$28.8K | ﹤0.01% | 6460 |
|
|
2022
Q4 | $60.3K | Sell |
2,000
-16,308
| -89% | -$492K | ﹤0.01% | 6210 |
|
|
2022
Q3 | $615K | Buy |
+18,308
| New | +$615K | ﹤0.01% | 5162 |
|